Sanchez-de la Rosa, Rainel; Sabater, Eliazar; Casado, … - In: Health Economics Review 3 (2013) 13, pp. 1-5
Background: Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim … of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the treatment of … glatiramer acetate and fingolimod, based on a 1-year time horizon. In addition to the pharmacological costs, resource use was …